All sessions are conducted through video webcasts and all times are in the Eastern time, US & Canada time zone. Provided below is the current Emerging Growth Conference schedule.
Register here to get the link to the conference and to be alerted as to when the conference starts.
Be sure to reference the Company the question is directed to.
AGBA Group Holding Limited (NASDAQ: AGBA) is a leading one-stop financial supermarket based in Hong Kong offering the broadest set of financial services and healthcare products in the Guangdong-Hong Kong-Macao Greater Bay Area (GBA) through a tech-led ecosystem, enabling clients to unlock the choices that best suit their needs.
Keynote speaker: Mr. Wing-Fai Ng, Group President of AGBA Group
Loop Industries, Inc. (NASDAQ: LOOP) is a technology company whose mission is to accelerate the world’s shift toward sustainable PET plastic and polyester fiber and away from our dependence on fossil fuels.
Keynote speaker: Kevin C. O’Dowd, VP Communications
CoTec Holdings Corp. (OTCQB: CTHCF) (TSXV: CTH) is an environment, social, and governance (“ESG”)-focused company investing in innovative technologies that have the potential to fundamentally change the way metals and minerals can be extracted and processed for the purpose of applying those technologies to undervalued operating assets and recycling opportunities, as the Company transitions into a mid-tier mineral resource producer.
Keynote speaker: Julian Treger, President / CEO
ASP Isotopes, Inc. (NASDAQ: ASPI) is an advanced materials company dedicated to developing technology and processes to produce isotopes in multiple industries.
Keynote speaker: Paul Elliot Mann, CEO
Akari Therapeutics, plc (NASDAQ: AKTX) is a biotechnology company developing advanced therapies for autoimmune and inflammatory diseases.
Keynote speaker: Rachelle Jacques, CEO
FendX Technologies, Inc. (OTCQB: FDXTF) (CSE: FNDX) is a Canada-based nanotechnology company focused on developing products to make people’s lives safer by reducing the spread of pathogens.
Keynote speaker: Carolyn Jane Myers, CEO
NeuroSense Therapeutics, Ltd. (NASDAQ: NRSN) is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases.
Keynote speaker: Alon Ben-Noon, Co-Founder, CEO & Director
Rakovina Therapeutics Inc. (TSXV: RKV) is focused on the development of new cancer treatments based on novel DNA-damage response technologies.
Keynote speaker: Jeffrey Bacha, Executive Chairman & David Hyman, President
Alpha Tau Medical, Inc. (NASDAQ: DRTS) is an Israeli medical device company that focuses on research, development, and potential commercialization of the Alpha DaRT for the treatment of solid tumors.
Keynote speaker: Raphi Levy, CFO
GeoVax Labs, Inc. (NASDAQ: GOVX) is a clinical-stage biotechnology company developing novel therapies and vaccines for solid tumor cancers and many of the world’s most threatening infectious diseases.
Keynote speaker: David Dodd, Chairman, President / CEO
NeuroMetrix, Inc. (NASDAQ: NURO) is a commercial stage healthcare company that develops and commercializes neurotechnology devices to address unmet needs in the chronic pain and diabetes markets.
Keynote speaker: Dr. Shai Gozani, CEO & Thomas Higgins, CFO
Theriva Biologics Inc., (NYSE American: TOVX) is a diversified clinical-stage company developing therapeutics designed to treat cancer and related diseases in areas of high unmet need.
Keynote speaker: Steven A. Shallcross, CEO / CFO
Bioxytran, Inc. (OTCQB: BIXT) is a clinical stage biotechnology company developing novel therapies targeting the treatment of significant unmet medical needs in virology, degenerative disease, and hypoxia.
Keynote speaker: Mike Sheikh, Executive Vice President Business Development
Inspire Veterinary Partners, Inc. (NASDAQ: IVP) is an owner/operator of veterinary hospitals in the US.
Keynote speaker: Kimball Carr, Chairman, President & CEO
BioLargo, Inc. (OTCQB: BLGO) is a clean-tech and life sciences innovator and engineering services solution provider.
Keynote speaker: Dennis Calvert, President / CEO
Nextech3D.ai, (OTCQX: NEXCF) (CSE: NTAR) (FSE: EP2), is a Company that provides AI-powered 3D and AR solutions for e-commerce, marketing and events.
Keynote speakers: Evan Gappelberg, CEO
Sokoman Minerals Corp., (OTCQB: SICNF) (TSXV: SIC) with its focus on its portfolio of gold projects is a discovery-oriented company with projects in the province of Newfoundland and Labrador, Canada.
Keynote speaker: Timothy Froude P. Geo. CEO, Pres & Director
Knightscope, Inc. (NASDAQ: KSCP) is an advanced public safety technology company that builds fully autonomous security robots and blue light emergency communications systems that help protect the places people live, work, study and visit.
Keynote speaker: William Santana Li, Chairman & CEO
Cyngn, Inc. (NASDAQ: CYN) develops and deploys scalable, differentiated autonomous vehicle technology for industrial organizations. Cyngn’s self-driving solutions allow existing workforces to increase productivity and efficiency.
Keynote speaker: Lior Tal, CEO & Director
Citizens, Inc. (NYSE: CIA) is a diversified financial services company providing life, living benefits and final expense insurance and other financial products to individuals and small businesses in the U.S., Latin America, and Asia.
Keynote speaker: Gerald W. Shields, Vice Chairman / CEO, & Jeff Conklin, CFO
Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) aims to be an innovative drug discovery and development company combining scientific, clinical, and manufacturing capabilities to develop novel therapies aimed at treating conditions for which limited treatment options exist.
Keynote speaker: Michael Martino, CEO & Director
Steppe Gold, Ltd. (OTCQX: STPGF) (TSX: STGO) is Mongolia’s premier precious metals company.
Keynote speakers: Aneel Singh, Exec. VP & Director
Regen BioPharma Inc. (OTC Pink: RGBP) is a biotechnology company focused on developing innovative treatments using autologous cell therapies, RNA and DNA-based immunotherapy and small molecules in the immune-oncology and autoimmune disease space.
Keynote speaker: David Koos, President / CEO & Harry M. Lander, Ph.D. Senior Scientific Consultant
The Emerging Growth Conference focus and coverage includes a wide range of growth sectors and timely market themes, including, augmented reality, artificial intelligence, scientific, medical instruments and therapeutics, biotechnologies, cannabis, food & beverage, energy and more.
Our conference serves as a vehicle for Emerging Growth to build relationships with our existing and potential clients. Accordingly, a certain number of the presenting companies are our current clients, and some may become our clients in the future. In exchange for services we provide, our clients pay us fees in the form of cash and securities, and we may currently have, or in the future may have investments in the securities of certain of the presenting companies. Finally, certain of the presenting companies have paid us a fee to secure a presentation time slot or to present generally.
The presentations to be delivered by the presenting companies (including any handouts of written materials) have not been approved, endorsed by or otherwise reviewed by EmergingGrowth.com nor should they in any way be construed to have been made in connection with the offer to sell or a solicitation of an offer to buy securities. Please consult an investment professional before investing in anything viewed on the Emerging Growth Conference or on EmergingGrowth.com.
Thank you for your interest in our conference, and we look forward to your participation in future conferences.
